Advanced search
Publication Cover
Journal of Drug Targeting Volume 23, 2015 - Issue 9
Submit an article Journal homepage
345
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET

Qing XuDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China,
,
Chen ZhuDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China,
,
Yuping XuKey Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China, and
,
Donghui PanKey Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China, and
,
Ping LiuSchool of Pharmaceutical Science, Zhengzhou University, Zhengzhou, China
,
Runlin YangKey Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China, and
,
Lizhen WangKey Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China, and
,
Fei ChenKey Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China, and
,
Xinchen SunDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China,
,
Shineng LuoDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, ;Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China, and Correspondence[email protected] [email protected]
&
Min YangDepartment of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, ;Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China, and
show all
Pages 813-820 | Received 18 Dec 2014, Accepted 16 Feb 2015, Published online: 11 Mar 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.